Catalyst Wire Dossier Catalyst Wire Dossier

HCV Adjuvanted Protein-based Vaccine Candidate

· University of Alberta
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCV Adjuvanted Protein-based Vaccine Candidate, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) [Phase 1]

See pricing